IntroductionThe editorial in the Tasman Medical Journal1 was a critique of my article in Quadrant entitled “The curious case of hydroxychloroquine”.2 It considered negative data from large clinical trials on hospitalised patients (The Recovery and Solidarity Trials), claimed scanty support
The editor of TMJ responds to a recent article in Quadrant promoting hydroxychloroquine in early COVID-19 infection. Review of the evidence does not support the use of hydroxychloroquine in this indication.
This paper describes the development and performance of an electronic data gathering system for intra-hospital ICU “Outreach” activity, and compares it with the paper-based system it displaced.
This article is a personal case report on the treatment of type 1 diabetes.
Australia’s response to environmental PFAS contamination to minimise toxicological effects has been excellent, but several problems remain. These relate to the design of the PFAS Taskforce website and its provenance. I discuss these matters in this review.
This paper describes a novel approach to treatment of young adult patients with Borderline Personality Disorder, in which the patient has the option of determining when he or she is admitted to a specialist custom clinical psychological unit during a relapse of symptoms. Preliminary data suggests that the approach is effective in reducing symptoms and frequency of admission.
This brief paper reviews the current situation in Australia over concern with environmental contamination by polyfluoroalkyls (PFAS).
This republished article describes the situation for nurses and nursing practice at the beginning of the COVID-19 pandemic. Originally published in the Journal of Evidence-based Nursing Practice
As a child the writer was told a joke about a liquid which dissolved everything. The question was what container could you keep it in?
Receive the Latest Tasman Medical Journal articles as they are published.
Subscription is free
Find out how to publish your work in the Tasman Medical Journal.
